Jerzy Szablowski
jerzyszablowski.bsky.social
Jerzy Szablowski
@jerzyszablowski.bsky.social
Assistant Professor at Rice Univ. Bioengineering. Developing molecular tools to interact with the brain and treat brain disorders.
Co-founder at Imprint Bio. Inc. NIH New Innovator, Packard Fellow, and DARPA YFA awardee.

www.szablowskilab.org
I wonder if it's a statistically significant uptick.
June 10, 2025 at 4:22 PM
It does take a lot. The hope is that all the companies doing BBB permeable AAVs like Apertura, Capsida, Sangamo, Voyager etc. will find something that works 10-100-fold more efficiently.
June 3, 2025 at 1:53 AM
Ultrasound BBB opening in large animals (or humans) is doable but somewhat complex. I do think the prices and complexity will go down over time for both gene delivery and BBB opening.
June 3, 2025 at 1:43 AM
Doing whole brain BBB-permeable gene delivery + with FUS release of synthetic markers could allow to study multiple sites without surgery and monitoring intracellular gene expression. e.g.
pubmed.ncbi.nlm.nih.gov/39110811/
Acoustically targeted measurement of transgene expression in the brain - PubMed
Gene expression is a critical component of brain physiology, but monitoring this expression in the living brain represents a major challenge. Here, we introduce a new paradigm called recovery of marke...
pubmed.ncbi.nlm.nih.gov
June 3, 2025 at 1:43 AM
That would be neat. Hong Chen at WUSTL has done some pioneering work in using FUS to release native proteins from the brain into the blood. There's non zero chance that native proteins carry sufficient information. If not, then the synthetic markers probably will, but would need gene delivery.
June 3, 2025 at 1:43 AM
What do you want to study? I am always curious about what are the experimental hurdles people have. I am wondering if it site-specific liquid biopsy would be useful for you. It's much more technically complicated but can study different regions on different days.
June 3, 2025 at 1:31 AM
There are some hurdles for human translation eg need for exogenous gene delivery. There are also ways to mitigate them. If our bright focus grant works out it should make translation realistic. There will be more work on optimization in nhps like higher signal, longer duration, recording c-fos etc
June 3, 2025 at 1:25 AM
Author list:
June 2, 2025 at 11:45 PM
Thanks Mark. I think we were surprised it worked so robustly. Still lots of work to do, in mice we could do orders of magnitude signal and track c-fos, arc etc. Next paper, if we can get the funding. This was done on a shoestring.
June 2, 2025 at 5:34 PM
www.biorxiv.org/content/10.1...

Lead author: Manwal Harb, who also contributed to engineering AAV.FUS, vector optimized for noninvasive site specific gene delivery to the brain.
www.nature.com/articles/s41...

Work supported by The G. Harold & Leila Y. Mathers Charitable Foundation
Site-Specific Noninvasive Delivery of Retrograde Viral Vectors to the Brain
Neuronal activity underlies the brain function. Different behaviors, physiological processes, and disorders depend on which neurons are active at a given moment. Treating brain disorders without side ...
www.biorxiv.org
April 26, 2025 at 8:53 PM
Jordan, we missed you at the ACS! I hope you're doing well
March 27, 2025 at 4:57 PM
i think it would be for more surprising if the mixture wasn't racemic...
February 4, 2025 at 11:15 PM
They are about a half of what we get paid here, but money isn't everything.
January 28, 2025 at 7:50 PM
this book brings back good memories!
December 17, 2024 at 4:27 AM